Luciferase Reporter Cell Line - KYSE-30

KYSE-30 is a human esophageal squamous cell carcinoma cell line widely utilized as an in vitro model to investigate the biological characteristics of esophageal cancer, including tumor growth, epithelial malignant transformation, signal pathway regulation, therapeutic response, and the molecular mechanisms associated with cancer progression. The parental KYSE-30 cell line was originally established from a human esophageal squamous cell carcinoma specimen. It is characterized by robust proliferative capacity under standard cell culture conditions, making it particularly suitable for experimental protocols requiring high reproducibility in cell growth and consistency in cellular behavior. The KYSE-30 Luciferase Reporter Cell Line is an engineered derivative of the parental KYSE-30 line, genetically modified to stably express a luciferase reporter gene. Through the stable integration or long-term maintenance of a luciferase expression cassette, this reporter cell line enables researchers to quantitatively assess viable tumor cells based on the intensity of bioluminescence signals following the addition of an appropriate luciferase substrate.

The KYSE-30 Luciferase Reporter Cell Line finds broad application in various cancer research and drug discovery projects. One of its most common applications involves cell viability and proliferation assays, wherein changes in luciferase activity serve as a rapid and sensitive indicator of tumor cell growth status or the degree of growth inhibition. This characteristic renders the cell line highly suitable for screening small-molecule compounds, biologics, natural products, targeted therapies, chemotherapeutic agents, or combination treatment strategies specifically targeting esophageal squamous cell carcinoma. In studies investigating cytotoxicity and apoptotic mechanisms, a reduction in bioluminescence signal intensity serves as a basis for assessing therapeutic response, dose-dependent inhibitory effects, and the kinetics of tumor cell killing over time. Furthermore, this cell line is well-suited for high-throughput and medium-throughput screening experiments, as luciferase-based detection methods are fully compatible with multi-well plates, automated liquid handling systems, and luminometer-based detection platforms. Beyond in vitro assays, KYSE-30-Luc cells are also invaluable for in vivo tumor xenograft studies.